Therapeutic Effect of Supercritical CO2 Extracts of Curcuma Species with Cancer Drugs in Rhabdomyosarcoma Cell Lines

Phytotherapy Research

Volumn 29, Issue 8, 2015, Pages 1152-1160

  Ramachandran, Cheppail ^a,b   Quirin, Karl W ^c   Escalon, Enrique A ^a   Lollett, Ivonne V ^b   Melnick, Steven J ^a,b  

^a MIAMI CHILDREN'S HOSPITAL   (United States)

^b Dharma Biomedical LLC   (United States)

^c FLAVEX Naturextrakte GmbH   (Germany)

Author keywords

apoptosis; Curcuma amada; gene expression; mango ginger; rhabdomyosaroma; xenografts

Indexed keywords

ANTINEOPLASTIC AGENT; CARBON DIOXIDE; CASPASE 3; CURCUMA AMADA EXTRACT; CURCUMA LONGA EXTRACT; CURCUMA XANTHORRHIZA EXTRACT; CYCLOOXYGENASE 2; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PLANT EXTRACT; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; SUPERCRITICAL CARBON DIOXIDE; UNCLASSIFIED DRUG; VINBLASTINE; CASP3 PROTEIN, HUMAN; TURMERIC EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BAK GENE; BAX GENE; BCL 2 GENE; CANCER INHIBITION; CANCER PROGNOSIS; CONTROLLED STUDY; COX 2 GENE; CURCUMA AMADA; CURCUMA LONGA; CURCUMA XANTHORRHIZA; DRUG CYTOTOXICITY; DRUG POTENTIATION; EMBRYONAL RHABDOMYOSARCOMA; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IC50; MALE; MONOTHERAPY; MOUSE; MOUSE MODEL; NF KAPPA B GENE; NONHUMAN; NUDE MOUSE; RHABDOMYOSARCOMA; RHABDOMYOSARCOMA CELL LINE; SJRH30 CELL LINE; SURVIVAL RATE; TUMOR SUPPRESSOR GENE; TUMOR XENOGRAFT; ANIMAL; CHEMISTRY; CLASSIFICATION; CURCUMA; DRUG EFFECTS; DRUG SCREENING; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

CURCUMA; CURCUMA AMADA; CURCUMA LONGA; CURCUMA XANTHORRHIZA; MUS MUSCULUS;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CASPASE 3; CELL LINE, TUMOR; CURCUMA; CYCLOPHOSPHAMIDE; DRUG SYNERGISM; HUMANS; INHIBITORY CONCENTRATION 50; MALE; MICE; MICE, NUDE; NF-KAPPA B; PLANT EXTRACTS; RHABDOMYOSARCOMA; VINBLASTINE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84938745281     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.5360     Document Type: Article

References (30)

1. Aggarwal BB, Kumar A, Bharti AC,. 2003. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 23: 363-398.
2. Amaral JD, Xavier JM, Steer CJ, Rodrigues CM,. 2010. The role of p53 in apoptosis. Discov Med 9: 145-152.
3. Cheah YH, Azimahtol HL, Abdullah NR,. 2006. Xanthorrhizol exhibits antiproliferative activity of MCF-7 breast cancer cells via apoptosis induction. Anticancer Res 26: 4527-4534.
4. Choi MA, Kim SH, Chung WY, Hwang JK, Park KK,. 2005. Xanthorrhizol, a natural sesquiterpenoid form Curcuma xanthrorrhiza, has an anti-metastatic potential in experimental mouse lung metastasis model. Biochem Biophys Res Commun 326: 210-217.
5. Chou TC, Talalay P,. 1983. Analysis of combined drug effects: a new look at a old problem. Trends Pharmacol Sci 4: 450-453.
6. Davicioni E, Anderson J, Finckenstein FG, et al,. 2009. Molecular classification of rhabdomyosarcoma-genotypic and phenotypic determinants of diagnosis: a report from the Children's Oncology Group. Am J Pathol 174: 550-564.
7. Dewson G, Kluck RM,. 2010. Bcl-2 family-regulated apoptosis in health and disease. Cell Health Cytoskelet 2: 9-22.
8. Elmore S,. 2007. Apoptosis: a review of programmed cell death. Toxicol Pathol 35: 495-516.
9. Fulda S,. 2012. Cell death pathways as therapeutic targets in rhabdomyosarcoma. Sarcoma. DOI: 10.1155/2012/326210.
10. Huh WW, Skapek SX,. 2010. Childhood rhabdomyosarcoma: new insight on biology and treatment. Curr Oncol Rep 12: 401-410.
11. Kang YJ, Park KK, Chung WY, Hwang JK, Lee SK,. 2009. Xanthorrhizol, a natural sequiterpenoid, induces apoptosis and growth arrest in HCT116 human colon cancer cells. J Pharmacol Sci 111: 276-284.
12. Kroemer G, Galluzzi L, Brenner C,. 2007. Mitochondrial membrane permeabilization in cell death. Physiol Rev 87: 99-163.
13. Malempati S, Hawkins DS,. 2012. Rhabdomyosarcoma: review of the Children's Oncology Group (COG) Soft-Tissue Sarcoma Committee experience and rationale for current COG studies. Pediatr Blood Cancer 59: 5-10.
14. Mandell LR,. 1993. Ongoing progress in the treatment of childhood rhabdomyosarcoma. Oncology 7: 71-83.
15. Minard-Colin V, Ichante JL, Nguyen L, et al,. 2012. Phase II study of vinorelbine and continuous low doses cyclophosphamide in children and young adults with a relapsed or refractory malignant solid tumour: good tolerance profile and efficacy in rhabdomyosarcoma-a report from the Société Française des Cancers et leucémies de l'Enfant et de l'adolescent (SFCE). Eur J Cancer 48: 2409-2416.
16. Pappo AS, Cristo WM, Wharam MD, et al,. 1999. Survival after relapse in children and adolescents with rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study Group. J Clin Oncol 17: 3487-3493.
17. Park JH, Park KK, Kim MJ, Hwang JK, Park SK, Chung WY,. 2008. Cancer chemoprotective effects of Curcuma xanthorrhiza. Phytother Res 22: 695-698.
18. Policegoudra RS,. 2008. Functional properties of bioactive molecules from mango ginger (Curcuma amada Roxb.) and its applications in food. PhD Thesis, Mysore University, Mysore, India.
19. Policegoudra RS, Rehna K, Jaganmohan Rao L, Aradhya SM,. 2010. Antimicrobial, antioxidant, cytotoxicity and platelet aggregation inhibitory activity of a novel molecule isolated and characterized from mango ginger (Curcuma amada Roxb.) rhizome. J Biosci 35: 231-240.
20. Policegoudra RS, Aradhya SM, Singh L,. 2011. Mango ginger (Curcuma amada Roxb.)-a promising spice for phytochemicals and biological activities. J Biosci 36: 739-748.
21. Ramachandran C, Wellham LL,. 2003. Effect of MDR1 phosphorothioate antisense oligodeoxynucleotides in multidrug-resistant human tumor cell lines and xenografts. Anticancer Res 23: 2681-2690.
22. Ramachandran C, Nair PKR, Alamo A, Cochrane CB, Escalon E, Melnick SJ,. 2006. Anticancer effects of amooranin in human colon carcinoma cell line in vitro and in nude mice xenorgrafts. Int J Cancer 119: 243-254.
23. Ramachandran C, Resek AP, Escalon E, Aviram A, Melnick SJ,. 2010. Potentiation of gemcitabine by Turmeric Force™ in pancreatic cancer cell lines. Oncol Rep 23: 1529-1535.
24. Ramachandran C, Nair SM, Escalon E, Melnick SJ,. 2012. Potentiation of etoposide and temozolomide cytotoxicity by curcumin and turmeric force™ in brain tumor cell lines. J Complement Integr Med 9: 20:. DOI: 10.1515/1553-3840.1614.
25. Saab R, Spunt SL, Skapek SX,. 2011. Myogenesis and rhabdomyosarcoma: the Jekyll and hyde of skeletal muscle. Curr Top Dev Biol 94: 197-234.
26. Schuler M, Bossy-Wetzel E, Goldstein JC, Fitzgerald P, Green DR,. 2000. p53 induces apoptosis by caspase activation through mitochondrial cytochrome c release. J Biol Chem 275: 7337-7342.
27. Seitz G, Warmann SW, Vokuhl CO, et al,. 2007. Effects of standard chemotherapy on tumor growth and regulation of multidrug resistance genes and proteins in childhood Rhabdomyosarcoma. Pediatr Surg Int 23: 431-439.
28. Singh S, Singh R, Banerjee S, Negi AS, Shanker K,. 2012. Determination of anti-tubercular agent in mango ginger (Curcuma amada Roxb.) by reverse phase HPLC-PDA-MS, chapter 2.4. Food Chem 131: 375-379.
29. Tee TT, Chea YH, Meenakshii N, Mohd Sharom MY, Azimahtol Hawariah LP,. 2012. Xanthorrhizol induced DNA fragmentation in HepG2 cells involving Bcl-2 family proteins. Biochem Biophys Res Commun 420: 834-838.
30. Wolff S, Erster S, Palacios G, Moll UM,. 2008. p53's mitochondrial translocation and MOMP action is independent of Puma and Bax and severely disrupts mitochondrial membrane integrity. Cell Res 18: 733-744.